Quantum chemical computations provide insight into liver toxicity
Balasubramanian and Basak have recently reported quantum chemical computations that enhance our understanding of mechanisms for the causes of liver toxicity.
May 6, 2016
0
1
Balasubramanian and Basak have recently reported quantum chemical computations that enhance our understanding of mechanisms for the causes of liver toxicity.
May 6, 2016
0
1
The HEMIBIO project has developed a Hepatic Microfluidic Bioreactor mimicking the structure of the human liver. The project team is confident that the new device will eventually help remove the need for testing chemicals ...
Nov 2, 2015
0
12
A panel of federal health advisers has backed the benefits of an experimental diabetes drug that uses a new method to reduce blood sugar, setting aside previous concerns about the pill's safety.
Dec 12, 2013
0
0
British Home Secretary Theresa May on Wednesday announced a ban on the herbal stimulant khat, going against the advice of her own experts who said such a move was disproportionate.
Jul 3, 2013
0
0
A panel of federal health advisers has narrowly recommended approval for an experimental antibiotic from Cempra Inc., a small North Carolina drugmaker.
Nov 4, 2016
0
1
Most patients suffering liver toxicity due to medications or herbal or dietary supplements recover from the acute liver injury without long-term problems, but some do not survive the injury or they require liver transplantation. ...
Jun 26, 2017
0
0
The human body critically depends on the liver to metabolize toxins and synthesize biomolecules necessary for life. In addition to being a site for life threatening diseases, the liver is particularly sensitive to damage ...
Feb 29, 2016
0
1
Researchers are working to improve drug testing to ensure newly developed drugs are safe for patients to take.
Oct 31, 2023
0
0
(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...
Jul 24, 2014
0
0
When a new drug is being developed, the first question is, "Does it work?" The second question is, "Does it do harm?" No matter how effective a therapy is, if it harms the patient in the process, it has little value.
Apr 8, 2021
0
1